Possible pathogenic mechanism of propofol infusion syndrome involves coenzyme Q

Anesthesiology

Volumn 122, Issue 2, 2015, Pages 343-352

  Vanlander, Arnaud Vincent ^a   Okun, Juergen Guenther ^b   De Jaeger, Annick ^a   Smet, Joél ^a   De Latter, Elien ^a   De Paepe, Boel ^a   Dacremont, Georges ^c   Wuyts, Birgitte ^a   Vanheel, Bert ^c   De Paepe, Peter ^a   Jorens, Philippe Germaine ^d   Van Regenmortel, Niels ^d,e   Van Coster, Rudy ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^c GHENT UNIVERSITY   (Belgium)

^d ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^e ZNA Hospital Network Antwerp   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CITRATE SYNTHASE; PROPOFOL; SUCCINATE DEHYDROGENASE (UBIQUINONE); UBIQUINOL CYTOCHROME C REDUCTASE; UBIQUINONE; INTRAVENOUS ANESTHETIC AGENT;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG DOSE INCREASE; DRUG TISSUE LEVEL; ELECTRON TRANSPORT; ENZYME ACTIVITY; HUMAN; HUMAN TISSUE; LIVER BIOPSY; MALE; MUSCLE BIOPSY; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROPOFOL INFUSION SYNDROME; RAT; RESPIRATORY CHAIN; SKELETAL MUSCLE; TISSUE HOMOGENATE; ANIMAL; ARTIFICIAL VENTILATION; CITRIC ACID CYCLE; DRUG EFFECTS; METABOLISM; SYNDROME; WISTAR RAT;

ANESTHETICS, INTRAVENOUS; ANIMALS; CITRIC ACID CYCLE; ELECTRON TRANSPORT; MALE; MUSCLE, SKELETAL; PROPOFOL; RATS; RATS, WISTAR; RESPIRATION, ARTIFICIAL; SYNDROME; UBIQUINONE;

EID: 84921950025     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0000000000000484     Document Type: Article

References (45)

1. Thompson KA, Goodale DB: The recent development of propofol (DIPRIVAN). Intensive Care Med 2000; 26(Suppl 4): S400-4
2. Adverse effects of propofol (Diprivan). Propofol (Diprivan) bivirkninger. Ugeskr Laeger 1990; 152:1176
3. Bray RJ: Propofol infusion syndrome in children. Paediatr Anaesth 1998; 8:491-9
4. Branca D, Roberti MS, Vincenti E, Scutari G: Uncoupling effect of the general anesthetic 2,6-diisopropylphenol in isolated rat liver mitochondria. Arch Biochem Biophys 1991; 290:517-21
5. Bains R, Moe MC, Vinje ML, Berg-Johnsen J: Sevoflurane and propofol depolarize mitochondria in rat and human cerebrocortical synaptosomes by different mechanisms. Acta Anaesthesiol Scand 2009; 53:1354-60
6. Rigoulet M, Devin A, Avéret N, Vandais B, Guérin B: Mechanisms of inhibition and uncoupling of respiration in isolated rat liver mitochondria by the general anesthetic 2,6-diisopropylphenol. Eur J Biochem 1996; 241:280-5
7. Cray SH, Robinson BH, Cox PN: Lactic acidemia and bradyarrhythmia in a child sedated with propofol. Crit Care Med 1998; 26:2087-92
8. Schenkman KA, Yan S: Propofol impairment of mitochondrial respiration in isolated perfused guinea pig hearts determined by reflectance spectroscopy. Crit Care Med 2000; 28:172-7
9. Kam PC, Cardone D: Propofol infusion syndrome. Anesthesia 2007; 62:690-701
10. Ypsilantis P, Politou M, Mikroulis D, Pitiakoudis M, Lambropoulou M, Tsigalou C, Didilis V, Bougioukas G, Papadopoulos N, Manolas C, Simopoulos C: Organ toxicity and mortality in propofol-sedated rabbits under prolonged mechanical ventilation. Anesth Analg 2007; 105:155-66
11. Jiang W, Yang ZB, Zhou QH, Huan X, Wang L: Lipid metabolism disturbances and AMPK activation in prolonged propofol-sedated rabbits under mechanical ventilation. Acta Pharmacol Sin 2012; 33:27-33
12. Mehta N, DeMunter C, Habibi P, Nadel S, Britto J: Short-term propofol infusions in children. Lancet 1999; 354:866-7
13. Wolf A, Weir P, Segar P, Stone J, Shield J: Impaired fatty acid oxidation in propofol infusion syndrome. Lancet 2001; 357:606-7
14. Withington DE, Decell MK, Al Ayed T: A case of propofol toxicity: Further evidence for a causal mechanism. Paediatr Anaesth 2004; 14:505-8
15. Baumeister FA, Oberhoffer R, Liebhaber GM, Kunkel J, Eberhardt J, Holthausen H, Peters J: Fatal propofol infusion syndrome in association with ketogenic diet. Neuropediatrics 2004; 35:250-2
16. Zytkovicz TH, Fitzgerald EF, Marsden D, Larson CA, Shih VE, Johnson DM, Strauss AW, Comeau AM, Eaton RB, Grady GF: Tandem mass spectrometric analysis for amino, organic, and fatty acid disorders in newborn dried blood spots: A twoyear summary from the New England Newborn Screening Program. Clin Chem 2001; 47:1945-55
17. Scholte HR, Ross JD, Blom W, Boonman AM, van Diggelen OP, Hall CL, Huijmans JG, Luyt-Houwen IE, Kleijer WJ, de Klerk JB, Przyrembel H, Verduin MH, Verstegen JC: Assessment of deficiencies of fatty acyl-CoA dehydrogenases in fibroblasts, muscle and liver. J Inherit Metab Dis 1992; 15:347-52
18. Fischer JC, Ruitenbeek W, Gabreëls FJ, Janssen AJ, Renier WO, Sengers RC, Stadhouders AM, ter Laak HJ, Trijbels JM, Veerkamp JH: A mitochondrial encephalomyopathy: The first case with an established defect at the level of coenzyme Q. Eur J Pediatr 1986; 144:441-4
19. Rustin P, Chretien D, Bourgeron T, Gérard B, Rötig A, Saudubray JM, Munnich A: Biochemical and molecular investigations in respiratory chain deficiencies. Clin Chim Acta 1994; 228:35-51
20. Hatefi Y, Stiggall DL: Preparation and properties of succinate: Ubiquinone oxidoreductase (complex II). Methods Enzymol 1978; 53:21-7
21. Sottocasa GL, Kuylenstierna B, Ernster L, Bergstrand A: An electron transport system associated with the outer membrane of liver mitochondria. J Cell Biol 1967; 32:415-38
22. Birch-Machin MA, Shepherd IM, Watmough NJ, Sherratt HS, Bartlett K, Darley-Usmar VM, Milligan DW, Welch RJ, Aynsley-Green A, Turnbull DM: Fatal lactic acidosis in infancy with a defect of complex III of the respiratory chain. Pediatr Res 1989; 25:553-9
23. DiMauro S, Servidels S, Zeviani M, DiRocco M, DeVivo DC, DiDonato S, Uziel G, Berry K, Hoganson G, Johnsen SD, Johnsen PC: Cytochrome c oxidase deficiency in Leigh syndrome. Ann Neurol 1987; 22:498-506
24. Srere PA: Citrate synthase. Methods Enzymol 1969; 13:3-5
25. Dupourque D, Kun E: Cytoplasmic and mitochondrial malate dehydrogenases from beef kidney: [EC 1.1.1.37 l-Malate: NAD oxidoreductase], Methods in Enzymology. Edited by Lowenstein JM. New York, Academic Press, 1969, pp 116-22
26. Bergmeyer HU, Gawehn K, Grassi, M: Methods of Enzymatic Analysis. Edited by Bergmeyer HU. New York, Academic Press, 1974, p 452
27. Schwab MA, Kölker S, van den Heuvel LP, Sauer S, Wolf NI, Rating D, Hoffmann GF, Smeitink JA, Okun JG: Optimized spectrophotometric assay for the completely activated pyruvate dehydrogenase complex in fibroblasts. Clin Chem 2005; 51:151-60
28. Kirby DM, Thorburn DR, Turnbull DM, Taylor RW: Biochemical assays of respiratory chain complex activity. Methods Cell Biol 2007; 80:93-119
29. Gellerich FN, Mayr JA, Reuter S, Sperl W, Zierz S: The problem of interlab variation in methods for mitochondrial disease diagnosis: Enzymatic measurement of respiratory chain complexes. Mitochondrion 2004; 4:427-39
30. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72:248-54
31. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193:265-75
32. Van Coster R, Smet J, George E, De Meirleir L, Seneca S, Van Hove J, Sebire G, Verhelst H, De Bleecker J, Van Vlem B, Verloo P, Leroy J: Blue native polyacrylamide gel electrophoresis: A powerful tool in diagnosis of oxidative phosphorylation defects. Pediatr Res 2001; 50:658-65
33. Smet J, De Paepe B, Seneca S, Lissens W, Kotarsky H, De Meirleir L, Fellman V, Van Coster R: Complex III staining in blue native polyacrylamide gels. J Inherit Metab Dis 2011; 34:741-7
34. Wittig I, Carrozzo R, Santorelli FM, Schägger H: Functional assays in high-resolution clear native gels to quantify mitochondrial complexes in human biopsies and cell lines. Electrophoresis 2007; 28:3811-20
35. Court MH, Hay-Kraus BL, Hill DW, Kind AJ, Greenblatt DJ: Propofol hydroxylation by dog liver microsomes: Assay development and dog breed differences. Drug Metab Dispos 1999; 27:1293-9
36. Ernster L, Dallner G: Biochemical, physiological and medical aspects of ubiquinone function. Biochim Biophys Acta 1995; 1271:195-204
37. Acco A, Bracht A: Transport, transformation and distribution space of propofol in the rat liver studied by means of the indicator-dilution technique. Xenobiotica 2004; 34:317-34
38. Marik PE: Propofol: An immunomodulating agent. Pharmacotherapy 2005; 25(5 Pt 2):28S-33S
39. Okun JG, Lümmen P, Brandt U: Three classes of inhibitors share a common binding domain in mitochondrial complex I (NADH:ubiquinone oxidoreductase). J Biol Chem 1999; 274:2625-30
40. Okun JG, Zickermann V, Brandt U: Properties of the common inhibitor-binding domain in mitochondrial NADHdehydrogenase (complex I). Biochem Soc Trans 1999; 27:596-601
41. Okun JG, Zickermann V, Zwicker K, Schägger H, Brandt U: Binding of detergents and inhibitors to bovine complex I-A novel purification procedure for bovine complex I retaining full inhibitor sensitivity. Biochim Biophys Acta 2000; 1459:77-87
42. Vanlander AV, Jorens PG, Smet J, De Paepe B, Verbrugghe W, Van den Eynden GG, Meire F, Pauwels P, Van der Aa N, Seneca S, Lissens W, Okun JG, Van Coster R: Inborn oxidative phosphorylation defect as risk factor for propofol infusion syndrome. Acta Anaesthesiol Scand 2012; 56:520-5
43. Mtaweh H, Bayir H, Kochanek PM, Bell MJ: Effect of a single dose of propofol and lack of dextrose administration in a child with mitochondrial disease: A case report. J Child Neurol 2013; 29:NP40-6
44. Savard M, Dupré N, Turgeon AF, Desbiens R, Langevin S, Brunet D: Propofol-related infusion syndrome heralding a mitochondrial disease: Case report. Neurology 2013; 81:770-1
45. Gurrieri C, Kivela JE, Bojanić K, Gavrilova RH, Flick RP, Sprung J, Weingarten TN: Anesthetic considerations in mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes syndrome: A case series. Can J Anaesth 2011; 58:751-63